Robert A. Lustig

faculty photo
Professor of Clinical Radiation Oncology
Department: Radiation Oncology

Contact information
Perelman Center for Advanced Medicine
Department of Radiation Oncology
3400 Civic Center Blvd
2nd floor West
Philadelphia, PA 19104
Office: 215-349-8429
Fax: 215-349-5445
Education:
BA (Biology)
Franklin and Marshall College, 1965.
MD
Jefferson Medical College, 1969.
Permanent link
 

Description of Itmat Expertise

Dr. Lustig's studies involve photodynamic therapy using new photosensitizers for clinical trials and the use of novel radiation sensitizers for the treatment of primary brain tumors.

Selected Publications

Rathore S,Akbari H, Rozycki M, Abdullah KG, Nasrallah MP, Binder ZA., Davuluri RV, Lustig RA,Dahmane N,Bilello M, O’Rourke D & Davatzikos D : Radiomic MRI signature reveals three distinct subtypes of glioblastoma with different clinical and molecular characteristics, offering prognostic value beyond IDH1. Scientific Reports 8(1): 5087, March 2018.

Rathore S; Akbari H; Doshi J; Shukla G; Rozycki M; Bilello M; Lustig R; Davatzikos C.: Radiomic signature of infiltration in peritumoral edema predicts subsequent recurrence in glioblastoma: implications for personalized radiotherapy planning. Journal of Medical Imaging 5(2), March 2018.

Birkhoff, S; Cantrell, M.; Moriarty, H; Lustig, R.: The Usability and Acceptability of a Patient-Centered Mobile Health Tracking App Among a Sample of Adult Radiation Oncology Patients. Advances in Nursing Science 00(00): 1-17, February 2018.

J. Vogel, S. Both, M. Kirk, C. Hann-Hsiang, R. Bagatell, Y. Li, R. Womer, N. Balamuth, A. Reilly, G. Kurtz, R. Lustig, Z. Touchner, C. Hill-Kayser: Proton Therapy for Pediatric head and neck malignancies. Pediactris Blood & Cancer October 2017.

Anamalayil SJ, Teo BK, Lin A, Lustig RA, Ahn PH: Effects of full-neck volumetric-modulated arc therapy vs split-field intensity-modulated head and neck radiation therapy on low neck targets and structures. Br J Radiol 89(1062), Jun 2016 Notes: Epub 2016 Apr 4.

Evans SM, Putt, M, Yang XY, Lustig RA, Martinez-Lage M, Williams D, Desai A, Wolf R, Brem S, Koch CJ: Initial evidence that blood-borne microvesicles are biomarkers for recurrence and survival in newly diagnosed glioblastoma patients. J Neurooncol 127(2): 391-400, April 2016 Notes: Epub 2016 Jan 8.

Sumei Wang, Maria Martinez-Lage, Yu Sakai, Sanjeev Chawla, Sungheon G. Kim, Michelle Alonso-Basanta, Robert A. Lustig, Steven Brem, Suyash Mohan, Ronald L. Wolf, Arati Desai, Harish Poptani: Differentiating Tumor Progression from Pseudo-progression in Patients with Glioblastomas using Diffusion ?Tensor Imaging and Dynamic Susceptibility. AJNR AM J Neuroradiol 37(1): 28-36, Jan 2016 Notes: Epub 2015 Oct 8.

Hill-Kayser CE, Gabriel P, Volz E, Lustig RA, Tochner Z, Hahn SM, Maity A. : Factors Associated with Event Reporting in the Pediatric Radiation Oncology Population Using and Electronic Incident Reporting System. Pract Radiat Oncol 5(5): 417-422, Sept-Oct 2015 Notes: Epub 2015 Jul 26.

Koch C, Lustig R, Xiang-Yang Y, Jenkins W, Wolf R, Martinex-Lage M, Desai A, Dewight W, and Evans, S.: Microvesicles as a Biomarker for Tumor Progression versus Treatment Effect in Radiation/Temozolomide-Treated Glioblastoma Patients. Transl Oncol 7(6): 752-8, Dec 2014.

Maquilan G, Grover S, Alonso-Basanta M, Lustig RA.: Acute toxicity profile of patients with low-grade gliomas and meningiomas receiving proton therapy. Am J Clin Oncol 37(5): 438-43, Oct 2014.

back to top
Last updated: 05/23/2018
The Trustees of the University of Pennsylvania